{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-GGP-00072",
      "entity_text" : "JAK",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "MAPK",
      "entity_type" : "family"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Concerning molecular diagnosis, it has been shown that activating mutations in the MAPK pathway leading to nuclear factor kappa beta (NFkappabeta) overactivation inhibits the Janus kinase (JAK)/STAT pathway 11, 19, in what was classically considered \" rasopathies.",
  "reading_complete" : "2020-08-02T10:43:46Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:42:36Z",
  "trigger" : "inhibits",
  "evidence" : [ "MAPK pathway leading to nuclear factor kappa beta (NFkappabeta) overactivation inhibits the Janus kinase (JAK" ],
  "pmc_id" : "5799629",
  "score" : 0
}